Intratumor hemodynamics using contrast-enhanced MRI in intra-arterial chemotherapy for head and neck cancer

Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Jun;133(6):706-715. doi: 10.1016/j.oooo.2021.11.007. Epub 2021 Nov 27.

Abstract

Objective: The objectives of the study were to estimate the perfusion of tumors by drugs used in intra-arterial chemotherapy for head and neck cancer with magnetic resonance imaging and to establish the factors involved in determining the optimal dose.

Study design: Contrast agent was administered intra-arterially into either the lingual or maxillary artery in 43 patients. Triple-phase continuous fast spin echo magnetic resonance imaging was performed. Changes in blood water longitudinal relaxation rate (⊿R1) were measured in relation to imaging phase, type of artery, measurement site, and tumor size.

Results: ⊿R1 was significantly higher at the tumor margin than at the center for both arteries, except in the first phase for the lingual artery. ⊿R1 was greatest in the third phase for the lingual artery and in the second phase for the maxillary artery. For both arteries, as the tumor size increased, there was a significant decrease in ⊿R1 at the center of the tumor compared with the margin.

Conclusions: The factors associated with ⊿R1 were imaging phase, type of artery, measurement site, and tumor size. When determining a drug's optimal dose, the type of artery and tumor size must be taken into consideration.

MeSH terms

  • Arteries
  • Contrast Media
  • Head and Neck Neoplasms* / diagnostic imaging
  • Head and Neck Neoplasms* / drug therapy
  • Hemodynamics
  • Humans
  • Magnetic Resonance Imaging* / methods

Substances

  • Contrast Media